Immune to Cancer: The CRI Blog
-
CRI Funded Scientist
Benjamin Izar, MD, PhD
Dr. Benjamin Izar’s work leverages natural and synthetic protein variants to enhance T cell function in cancer… -
CRI Funded Scientist
Paul Beavis, PhD
Dr. Paul Beavis is pioneering strategies to enhance CAR T cell therapy for solid cancers. His research… -
CRI Funded Scientist
Luke Postoak, PhD
Dr. Luke Postoak is investigating the process of antigen cross-presentation, where dendritic cells degrade cancer cells to… -
CRI Funded Scientist
Ayana T. Ruffin, PhD
Dr. Ayana Ruffin is investigating the intricacies of immune response in melanoma patients, focusing on a therapeutic… -
CRI Funded Scientist
Ze Zhang, PhD
Dr. Ze Zhang is initiating a groundbreaking study to understand the NLRP1 inflammasome, a critical component of… -
CRI Funded Scientist
Yi Yang, PhD
Dr. Yi Yang aims to elucidate the limitations of laboratory mice in modeling human immune responses. She… -
CRI Funded Scientist
Yang Zhao, PhD
Dr. Yang Zhao is developing a safer and more effective CAR-T therapy with a specific focus on… -
CRI Funded Scientist
Xiang Li, PhD
Dr. Xiang Li is exploring the intricacies of our immune system, focusing on B cells and B… -
CRI Funded Scientist
Norihide Jo, MD, PhD
Dr. Norihide Jo is researching Follicular Dendritic Cell (FDC) development. FDC are vital for capturing and retaining…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.